Amphastar Pharmaceuticals Total Liabilities 2012-2024 | AMPH
Amphastar Pharmaceuticals total liabilities from 2012 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Amphastar Pharmaceuticals Annual Total Liabilities
(Millions of US $) |
| 2023 |
$873 |
| 2022 |
$213 |
| 2021 |
$226 |
| 2020 |
$183 |
| 2019 |
$159 |
| 2018 |
$149 |
| 2017 |
$117 |
| 2016 |
$98 |
| 2015 |
$95 |
| 2014 |
$108 |
| 2013 |
$87 |
| 2012 |
$84 |
| 2011 |
$0 |
| 2009 |
$141 |
Amphastar Pharmaceuticals Quarterly Total Liabilities
(Millions of US $) |
| 2024-06-30 |
$778 |
| 2024-03-31 |
$902 |
| 2023-12-31 |
$873 |
| 2023-09-30 |
$949 |
| 2023-06-30 |
$789 |
| 2023-03-31 |
$225 |
| 2022-12-31 |
$213 |
| 2022-09-30 |
$222 |
| 2022-06-30 |
$224 |
| 2022-03-31 |
$237 |
| 2021-12-31 |
$226 |
| 2021-09-30 |
$222 |
| 2021-06-30 |
$199 |
| 2021-03-31 |
$195 |
| 2020-12-31 |
$183 |
| 2020-09-30 |
$163 |
| 2020-06-30 |
$158 |
| 2020-03-31 |
$149 |
| 2019-12-31 |
$159 |
| 2019-09-30 |
$152 |
| 2019-06-30 |
$169 |
| 2019-03-31 |
$164 |
| 2018-12-31 |
$149 |
| 2018-09-30 |
$139 |
| 2018-06-30 |
$131 |
| 2018-03-31 |
$123 |
| 2017-12-31 |
$117 |
| 2017-09-30 |
$107 |
| 2017-06-30 |
$111 |
| 2017-03-31 |
$110 |
| 2016-12-31 |
$98 |
| 2016-09-30 |
$100 |
| 2016-06-30 |
$101 |
| 2016-03-31 |
$98 |
| 2015-12-31 |
$95 |
| 2015-09-30 |
$111 |
| 2015-06-30 |
$114 |
| 2015-03-31 |
$117 |
| 2014-12-31 |
$108 |
| 2014-09-30 |
$118 |
| 2014-06-30 |
$110 |
| 2014-03-31 |
$94 |
| 2013-12-31 |
$87 |
| 2013-09-30 |
$0 |
| 2013-06-30 |
$0 |
| 2013-03-31 |
$0 |
| 2012-12-31 |
$84 |
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.469B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
